Back to Trades
Dunlop A. Sinclair
InsiderCIK 0001721108
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2025–2026
Dunlop A. Sinclair has filed 5 SEC reports (2025–2026), all concentrated in Apellis Pharmaceuticals, Inc. (APLS), totaling $6.8M in disclosed volume. Weighing $0 bought versus $2.2M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Insider | Disposed | $4.3M |
| Jan 5 | APLS Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Director | Grant | $368.9K |
| Oct 15 | APLS Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Insider | Sell | $737.5K |
| Oct 2 | APLS Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Insider | Sell | $702.1K |
| Sep 19 | APLS Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Insider | Sell | $713.6K |
5 filings